What caused the ALINT.PA stock spike today?

A large intraday volume surge pushed ALINT.PA stock to EUR 0.18, up 22.03%. The move followed buying above the 50-day average and short-term oversold technicals. No confirmed company announcement was the primary driver.

Is ALINT.PA stock a buy after the intraday rise?

Meyka AI rates ALINT.PA B (HOLD). Short-term traders may exploit momentum, but longer-term investors should wait for earnings improvement and cash-flow stability before buying.

What are the key risks for ALINT.PA stock?

Key risks include negative EPS, limited liquidity, debt-to-equity of 1.23, and a wide 52-week range. Volatility can generate rapid losses without strict risk management.

What price should traders watch for confirmation?

Watch confirmation above intraday high EUR 0.19 for upside continuation; a break below EUR 0.1505 would negate the rally and increase downside risk to the year low EUR 0.115.

EU Stocks

ALINT.PA stock up 22% intraday on EURONEXT: volume spike offers key setup

ByHuzaifa Zahoor March 24, 2026

ALINT.PA stock jumped 22.03% intraday on 24 Mar 2026, trading at EUR 0.18 on EURONEXT after a burst of buying volume. Volume climbed to 48,897 shares versus a 3-month average of 12,329, driving the price from an open of EUR 0.1505 to a session high of EUR 0.19. The move snapped a short-term downtrend and put ALINT.PA back above its 50-day average of EUR 0.16. We examine whether the volume spike reflects a genuine technical rebound or a short-lived momentum trade for this France-based biotechnology services provider.